Project Medishare | GHESKIO research featured in New England Journal of Medicine
post-template-default,single,single-post,postid-817,single-format-standard,ctct-elision,ajax_fade,page_not_loaded,,qode-theme-ver-3.2,wpb-js-composer js-comp-ver-4.12,vc_responsive


GHESKIO research featured in New England Journal of Medicine

  |   Celebrities

By Jennifer Browning

The Haitian Group for the Study of Kaposi’s Sarcoma and Opportunistic Infections (GHESKIO) was featured in the August 20 edition of the New England Journal of Medicine where follow-up data was released regarding the detailed outcomes of GHESKIO patients after five years of receiving anti-retroviral therapy (ART).

Prior to using ART in Haiti (2003), 90 percent of AIDS patients died in less than a year and all were dead at the end of two years. The article reports finding that patients followed after receiving ART had a 90 percent survival rate after one year and a 79 percent survival rate after five years. The findings outcomes are comparable to the most advance hospitals in the United States.

GHESKIO physicians began there battle with AIDS in Haiti in the late 1970s.

“GEHSKIO physicians would not have dreamed that this day would have been possible less than thirty years from the days when the disease was barely defined, let alone thought survivable,” Projects Administrator Sandra Camille, Projects Administrator at GHESKIO said. “We are grateful to all partners, colleagues, and supporters and continuing our work together towards the realization of an HIV/AIDS free Haiti.”

Click here to read the 5-Year Survival of Patients with AIDS Receiving Antiretroviral Therapy in Haiti. (August 20, 2009)

Click here to read the Antiretroviral Therapy in a Thousand Patients with AIDS in Haiti. (December 1, 2005)